Biological E

Highly Engaged Employees

Biological E is a prominent biopharmaceutical entity established in 1953, specializing in the development, manufacturing, and supply of vaccines, injectable pharmaceuticals, and specialty biologic products. The company maintains a robust portfolio of active pharmaceutical ingredients and therapeutic molecules, serving both domestic and international markets. By prioritizing advanced manufacturing and rigorous regulatory compliance, Biological E addresses critical medical needs and infectious diseases, positioning itself as a key player in the global healthcare landscape.

Operating with a workforce of 5,000-10,000 employees across 4 strategic locations, the organization leverages extensive research capabilities to drive public health initiatives. Meet Biological E's team to understand the leadership and technical expertise driving their operational success. The company integrates high-quality production standards with global partnerships to ensure the delivery of affordable healthcare solutions, maintaining a significant presence in the pharmaceutical sector through its commitment to innovation and scalable manufacturing processes.

With a reported annual revenue of $2.2B, Biological E demonstrates strong market performance and financial stability. The company’s growth is further supported by strategic investments, including a $5.0M grant from the Coalition for Epidemic Preparedness Innovations in 2020 to bolster vaccine development efforts. Explore financial highlights to review detailed metrics regarding their fiscal trajectory and investment history. Through its focus on specialty biologics and vaccine production, the firm continues to expand its influence in the biopharmaceutical industry, consistently meeting the evolving demands of global health systems.